The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study-Reference-Cited by-同舟云学术

The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study

Published:2016-03 Issue:2 Volume:83 Page:167-171
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Hoxha Ariela,Calligaro Antonia,Tonello Marta,Ramonda Roberta,Carletto Antonio,Paolazzi Giuseppe,Bortolotti Roberto,Del Ross Teresa,Grava Chiara,Boaretto Massimo,Favaro Maria,Teghil Vera,Ruffatti Amelia,Punzi Leonardo

Publisher

Elsevier BV

Subject

Rheumatology

Reference30 articles.

1. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial;van der Heijde;Arthritis Rheum,2006

2. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial;Weinblatt;Arthritis Rheum,2003

3. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial;Mease;Arthritis Rheum,2005

4. Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial;van der Heijde;Ann Rheum Dis,2009

5. Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation;de Vries;Ann Rheum Dis,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Correlation between Anti-drug Antibodies and Therapeutic Response in Tunisian Patients with Chronic Inflammatory Diseases Treated by TNF Blockers;Current Rheumatology Reviews;2024-09

2. Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial;Rheumatology International;2024-07-24

3. Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?;Clinical Proteomics;2023-06-10

4. Therapeutic drug monitoring of disease-modifying antirheumatic drugs in circulating leukocytes in immune-mediated inflammatory diseases;Inflammopharmacology;2023-05-09

5. Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients;Frontiers in Immunology;2022-06-17